Publication
Low carbon projects
Low carbon projects, especially those involving hydrogen and Carbon Capture and Storage (CCS), play a crucial role in the journey towards global decarbonisation.
Indonesia | Publication | May 2022
The Indonesian Government has just issued a ban on palm oil export. The ban was officially announced by President Joko Widodo on 27 April 2022. This was then confirmed through the issuance of Ministry of Trade Regulation No. 22 of 2022 on the Temporary Export Ban for Crude Palm Oil, Refined, Bleached and Deodorized Palm Oil, Refined, Bleached and Deodorized Palm Olein, and Used Cooking Oil (MOT Reg. 22/2022).
The Government stated that export ban is driven by the domestic shortage in the supply of cooking oil, which has led to price surges. The Government added that the aim of the export ban is to ensure and maintain the domestic price of cooking oil at IDR 14,000 / litre.
MOT Reg. 22/2022 temporarily bans the export of the following commodities:
MOT Reg 22/2022 stipulates that exporters who have obtained customs clearance by 27 April 2022 for the export of any of the aforementioned commodities may still proceed with the export. Otherwise, the export ban is effective as of 28 April 2022, with no written indication as to how long this temporary ban will remain in force. The government has indicated that the ban will likely remain in effect until domestic prices are under control.
We will continue to monitor the impact and development of this matter and keep you updated. If you have any questions in relation to this matter, please contact Kresna Panggabean or Jeremiah Purba.
Publication
Low carbon projects, especially those involving hydrogen and Carbon Capture and Storage (CCS), play a crucial role in the journey towards global decarbonisation.
Publication
Taking your company public is an important milestone, and whilst the landscape for IPOs is complex and dynamic, choosing the right path is essential.
Publication
The budget reconciliation bill (P.L. 119-21), known as the “One Big Beautiful Bill,” marks a fundamental and far-reaching overhaul of the US healthcare system, ushering in the most significant retractions and changes since the Affordable Care Act in 2010.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright US LLP 2025